Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roumen Milev

Showing results (1-10 of 172) with videos related to

Pageof 18
Sort By:
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|June 5, 2003
Switch to mania upon discontinuation of antidepressants in patients with mood disorders: a review of the literatureSherese Ali, Roumen Milev
JMIR Research Protocols|June 5, 2020
The Safety, Efficacy, and Tolerability of Microbial Ecosystem Therapeutic-2 in People With Major Depression and/or Generalized Anxiety Disorder: Protocol for a Phase 1, Open-Label StudyArthi Chinna Meyyappan, Roumen Milev
Annals of General Psychiatry|March 14, 2017
Erratum to: The effects of probiotics on depressive symptoms in humans: a systematic reviewCaroline J K Wallace, Roumen Milev
Frontiers in Psychiatry|October 17, 2017
Olfactory Functioning and Depression: A Systematic ReviewHannah Taalman, Caroline Wallace, Roumen Milev
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|August 29, 2006
Add-on quetiapine for bipolar depression: a 12-month open-label trialRoumen Milev, Gebrehiwot Abraham, Juveria Zaheer
Annals of General Psychiatry|February 28, 2017
The effects of probiotics on depressive symptoms in humans: a systematic reviewCaroline J K Wallace, Roumen Milev
Interactive Journal of Medical Research|January 21, 2022
Microbial Ecosystem Therapeutic-2 Intervention in People With Major Depressive Disorder and Generalized Anxiety Disorder: Phase 1, Open-Label StudyArthi Chinna Meyyappan, Evan Forth, Roumen Milev
Journal of Affective Disorders|February 18, 2006
T3 augmentation of SSRI resistant depressionGebrehiwot Abraham, Roumen Milev, J Stuart Lawson
Neuropsychiatric Disease and Treatment|January 29, 2013
A review of electroencephalographic changes in diabetes mellitus in relation to major depressive disorderAnusha Baskaran, Roumen Milev, Roger S McIntyre
Neuropharmacology|May 10, 2012
The neurobiology of the EEG biomarker as a predictor of treatment response in depressionAnusha Baskaran, Roumen Milev, Roger S McIntyre
Pageof 18

Showing results (1-10 of 172) with videos related to

Sort By:
Pageof 18
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|June 5, 2003
Switch to mania upon discontinuation of antidepressants in patients with mood disorders: a review of the literatureSherese Ali, Roumen Milev
JMIR Research Protocols|June 5, 2020
The Safety, Efficacy, and Tolerability of Microbial Ecosystem Therapeutic-2 in People With Major Depression and/or Generalized Anxiety Disorder: Protocol for a Phase 1, Open-Label StudyArthi Chinna Meyyappan, Roumen Milev
Annals of General Psychiatry|March 14, 2017
Erratum to: The effects of probiotics on depressive symptoms in humans: a systematic reviewCaroline J K Wallace, Roumen Milev
Frontiers in Psychiatry|October 17, 2017
Olfactory Functioning and Depression: A Systematic ReviewHannah Taalman, Caroline Wallace, Roumen Milev
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|August 29, 2006
Add-on quetiapine for bipolar depression: a 12-month open-label trialRoumen Milev, Gebrehiwot Abraham, Juveria Zaheer
Annals of General Psychiatry|February 28, 2017
The effects of probiotics on depressive symptoms in humans: a systematic reviewCaroline J K Wallace, Roumen Milev
Interactive Journal of Medical Research|January 21, 2022
Microbial Ecosystem Therapeutic-2 Intervention in People With Major Depressive Disorder and Generalized Anxiety Disorder: Phase 1, Open-Label StudyArthi Chinna Meyyappan, Evan Forth, Roumen Milev
Journal of Affective Disorders|February 18, 2006
T3 augmentation of SSRI resistant depressionGebrehiwot Abraham, Roumen Milev, J Stuart Lawson
Neuropsychiatric Disease and Treatment|January 29, 2013
A review of electroencephalographic changes in diabetes mellitus in relation to major depressive disorderAnusha Baskaran, Roumen Milev, Roger S McIntyre
Neuropharmacology|May 10, 2012
The neurobiology of the EEG biomarker as a predictor of treatment response in depressionAnusha Baskaran, Roumen Milev, Roger S McIntyre
Pageof 18